Page last updated: 2024-09-05

sorafenib and biochanin a

sorafenib has been researched along with biochanin a in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(biochanin a)
Trials
(biochanin a)
Recent Studies (post-2010) (biochanin a)
6,5207305,2514276224

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)biochanin a (IC50)
Lysine-specific histone demethylase 1AHomo sapiens (human)2.95
AromataseHomo sapiens (human)0.0102
Amine oxidase [flavin-containing] AHomo sapiens (human)0.4
Amine oxidase [flavin-containing] BHomo sapiens (human)0.4
17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)9.9
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)Plasmodium falciparum (malaria parasite P. falciparum)8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Naim, AB; Badawy, NN; El-Ahwany, E; Khalifa, AE; Liu, AW; Tolba, MF; Youssef, MM; Zada, S1

Other Studies

1 other study(ies) available for sorafenib and biochanin a

ArticleYear
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells.
    Scientific reports, 2016, 07-29, Volume: 6

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Genistein; Hepatocytes; Humans; Inhibitory Concentration 50; Niacinamide; Phenylurea Compounds; Sorafenib

2016